Physician profile
Micaela Collins
NPI 1346807450
$1,371.42
in general payments reported to CMS, 2019-2025
13 companies · $707 in 2025
The $707 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.19 · 2021: $42.83 · 2022: $68.19 · 2023: $331 · 2024: $168 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,206.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $320.60 | 2023-2024 | Progel Applicator Spray Tips, Phasix Mesh |
| Edwards Lifesciences Corporation | $241.38 | 2025 | Konect Resilia |
| Kci USA, INC. | $165.21 | 2019-2022 | |
| Abiomed | $157.69 | 2025 | |
| On Target Laboratories, INC | $149.91 | 2025 | Cytalux |
| Haemonetics Corporation | $95.07 | 2023 | Teg6s Hemostasis System |
| Atricure, INC. | $85.34 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Abbvie INC. | $43.22 | 2023-2024 | Qulipta |
| Medtronic, INC. | $41.48 | 2025 | Avalus |
| Getinge USA Sales, LLC | $31.23 | 2025 | Vasoview Hemopro 2 |
| Baxter Healthcare | $21.32 | 2024 | Floseal, Perclot, Tisseel |
| Ethicon US, LLC | $15.98 | 2023 | Prolene, Monocryl, Vicryl |
| Intuitive Surgical, INC. | $2.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micaela Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.